Mesoblast Limited vs J M Smucker Co — how do they compare? Mesoblast Limited trades at $16.5 (market cap $2.20B), while J M Smucker Co trades at $120.75 (market cap $12.70B). The key difference: J M Smucker Co is far larger — about 5.8× Mesoblast Limited's market cap, and J M Smucker Co pays a 3.77% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.
| MESO | SJM | |
|---|---|---|
Market Cap | $2.20B | $12.70B |
Sector | Technology | Consumer Staples |
52-Week High | $20.96 | $126.35 |
52-Week Low | $12.88 | $89.53 |
Enterprise Value | $2.20B | $19.73B |
Dividend Yield | — | 3.77% |
Trailing returns across standard periods
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →J.M. Smucker is a packaged food company that primarily operates in the U.S. retail channel (87% of fiscal 2022 revenue), but also in U.S. food-service (7%), and international (6%). Its largest segment is pet food and treats (36% of 2022 revenue), with popular brands such as Milk-Bone, Meow Mix, 9Lives, Kibbles 'n Bits, Nature's Recipe, and Rachael Ray Nutrish. Its second-largest category is coffee (35% across channels) with the number-two brand Folgers and number-six Dunkin'. Other large categories are peanut butter (10%), with number-one Jif, fruit spreads (5%) with number-one Smucker's, and frozen hand-held foods (6%) with number-one Uncrustables.
Read more on SJM →